RenovoRx, Inc.
(NASDAQ: RNXT)
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
0.941
-0.009
(-0.95%)
Range
0.926 - 0.970
(4.75%)
Open
0.950
Previous Close
0.950
Bid Price
2.070
Bid Volume
11
Ask Price
2.100
Ask Volume
22
Volume
113,155
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
